AstraZeneca Annual Report and Financial Statements 90 Form 20-F Information 2004 Notes to the Financial Statements continued 14 Short term investments 2004 2003 $m $m Listed debt securities 3 Other listed investments 14 54 Investment securities 14 57 Fixed deposits 4,077 3,161 4,091 3,218 The Groups insurance subsidiaries hold cash and short term investments totalling $326m 2003 $298m, of which $207m 2003 $195m is required to meet insurance solvency requirements and which, as a result, is not readily available for the general purposes of the Group.
15 Short term borrowings and overdrafts 2004 2003 $m $m Bank borrowings Fixed securities 12 7 Unsecured 130 145 142 152 16 Other creditors 2004 2003 $m $m Amounts due within one year Trade creditors 3,125 3,086 Corporate taxation 967 1,353 Value added and payroll taxes and social security 282 255 Other creditors 1,008 946 Accruals 1,197 989 Dividends to shareholders 1,061 914 7,640 7,543 Amounts due after more than one year Other creditors 78 52 Included in other creditors are amounts totalling $138m 2003 $104m to meet insurance obligations of the Groups insurance subsidiaries.
Also in other creditors are amounts due within one year in connection with the Groups exceptional charges, including $39m 2003 $54m in respect of the Agrochemicals demerger and Specialties disposal.
